Abstract:AIM: To investigate the expression of toll-like receptor (TLR) 4, nuclear factor-kappa B (NF-kappa B) p65 and hypoxia-inducible transcription factor 1 alpha (HIF-1 alpha) in pancreatic ductal adenocarcinoma and their clinical significance.METHODS: The mRNA of TLR4 and HIF-1 alpha were investigated by real-time polymerase chain reaction in 30 cases of pancreatic ductal adenocarcinoma and its adjacent tissues, and expression of TLR4, NF-kappa B p65 and HIF-1 alpha protein were detected by immunohistochemistry in 65 cases of pancreatic ductal adenocarcinoma tissues and 38 cases of corresponding adjacent tissues. The relationship between TLR4 or HIF-1 alpha and pathologic features, as well as the association between TLR4 and HIF-1 alpha, were also analyzed. Kaplan-Meier method was used to assess the impact of expression of TLR4 and HIF-1 alpha on survival of patients with pancreatic cancer.RESULTS: The relative quantification of TLR4 and HIF-1 alpha mRNA in tumor tissues was 0.81 +/- 0.10 and 0.87 +/- 0.11, respectively, significantly higher than that in adjacent tissues (0.81 +/- 0.10 vs 0.70 +/- 0.16, P = 0.002; 0.87 +/- 0.11 vs 0.68 +/- 0.13, P = 0.000). The protein expression of TLR4, NF-kappa B p65 and HIF-1 alpha in tumor tissues was 69.20%, 66.15% and 70.80%, respectively, being significantly higher than that in adjacent normal tissues (69.20% vs 39.50%, P = 0.003; 66.15% vs 31.58%, P = 0.001; 70.80% vs 36.80%, P = 0.001). There was no significant correlation between TLR4 or HIF-1 alpha expression and the age, gender, tumor location, the degree of tumor differentiation in the patients (P > 0.05). However, there was significant correlation between the expression of TLR4 or HIF-1 alpha and tumor size, lymph node metastasis, venous invasion and clinical staging (P < 0.05). The expression of TLR4 and HIF-1 alpha had a significant impact on survival of patients with pancreatic adenocarcinoma.CONCLUSION: TLR4, NE-kappa B p65 and HIF-1 alpha are overexpressed in pancreatic adenocarcinoma, TLR4 may be partly involved in up-regulating HIF-1 alpha, and both synergestically promote development of pancreatic adenocarcinoma. (C) 2010 Baishideng. All rights reserved.

Expression of classical human leukocyte antigen class I antigens, HLA‐E and HLA‐G, is adversely prognostic in pancreatic cancer patients

High Expression of Human Leukocyte Antigen-G is Associated with a Poor Prognosis in Patients with PDAC.

Interplay between B7–H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma

Prognostic Value of Programmed Cell Death Protein 1 Expression on CD8+ T Lymphocytes in Pancreatic Cancer

Cytoplasmic HSP90α Expression is Associated with Perineural Invasion in Pancreatic Cancer.

Elevated glypican‐1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma

Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma

Prognostic Impact of Human Lymphocyte Antigen (HLA) Class I Expression in Patients With Breast Cancer

Prognostic Value of HLA Class I in Patients with Hepatocellular Carcinoma

Clinicopathological Significance of Expression of HIF-1α and P-gp in Pancreatic Carcinoma

Poor clinical outcomes and immunoevasive contexture in CD161+CD8+ T cells barren human pancreatic cancer

Expression of Hypoxia-Inducible Factor-1 Alpha and Associated Proteins in Pancreatic Ductal Adenocarcinoma and Their Impact on Prognosis

The PD-L1 Expression and Tumor-Infiltrating Immune Cells Predict an Unfavorable Prognosis in Pancreatic Ductal Adenocarcinoma and Adenosquamous Carcinoma.

High Expression of Cancer-Derived Glycosylated Immunoglobulin G Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma

Specific human leukocyte antigen class I genotypes predict prognosis in resected pancreatic adenocarcinoma: a retrospective cohort study

Expression and clinical significance of PD-L1 and infiltrated immune cells in the gastric adenocarcinoma microenvironment

PD-L1 and PD-L2 expression in pancreatic ductal adenocarcinoma and their correlation with immune infiltrates and DNA damage response molecules

MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapy

Clinical significance of xpression of HIF-1α and EMT related actors in pancreatic ductal adenocarcinoma

Expression and Significance of TLR4 and HIF-1α in Pancreatic Ductal Adenocarcinoma

The Combination of a Nuclear HMGB1-positive and HMGB2-negative Expression is Potentially Associated with a Shortened Survival in Patients with Pancreatic Ductal Adenocarcinoma